Arakaki AK[Author] - Search Results

Year	Number of Results
1994	3
1997	1
1998	1
1999	1
2000	2
2001	1
2003	2
2004	3
2005	2
2006	2
2007	1
2008	4
2009	2
2010	1
2018	2
2021	2
2022	1
2023	1
2024	0

1

GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling.

Arakaki AKS, Pan WA, Trejo J. Arakaki AKS, et al. Int J Mol Sci. 2018 Jun 27;19(7):1886. doi: 10.3390/ijms19071886. Int J Mol Sci. 2018. PMID: 29954076 Free PMC article. Review.

2

Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers.

Arakaki AKS, Szulzewsky F, Gilbert MR, Gujral TS, Holland EC. Arakaki AKS, et al. Neuro Oncol. 2021 Nov 2;23(23 Suppl 5):S4-S15. doi: 10.1093/neuonc/noab183. Neuro Oncol. 2021. PMID: 34725698 Free PMC article. Review.

3

Prediction of physical protein-protein interactions.

Szilágyi A, Grimm V, Arakaki AK, Skolnick J. Szilágyi A, et al. Among authors: arakaki ak. Phys Biol. 2005 Jun;2(2):S1-16. doi: 10.1088/1478-3975/2/2/S01. Phys Biol. 2005. PMID: 16204844 Review.

4

Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice.

Szulzewsky F, Arora S, Arakaki AKS, Sievers P, Almiron Bonnin DA, Paddison PJ, Sahm F, Cimino PJ, Gujral TS, Holland EC. Szulzewsky F, et al. Among authors: arakaki aks. Genes Dev. 2022 Aug 25;36(13-14):857-70. doi: 10.1101/gad.349876.122. Online ahead of print. Genes Dev. 2022. PMID: 36008139 Free PMC article.

5

Functional plasticity and catalytic efficiency in plant and bacterial ferredoxin-NADP(H) reductases.

Ceccarelli EA, Arakaki AK, Cortez N, Carrillo N. Ceccarelli EA, et al. Among authors: arakaki ak. Biochim Biophys Acta. 2004 May 6;1698(2):155-65. doi: 10.1016/j.bbapap.2003.12.005. Biochim Biophys Acta. 2004. PMID: 15134648 Review.

6

Plant-type ferredoxin-NADP+ reductases: a basal structural framework and a multiplicity of functions.

Arakaki AK, Ceccarelli EA, Carrillo N. Arakaki AK, et al. FASEB J. 1997 Feb;11(2):133-40. doi: 10.1096/fasebj.11.2.9039955. FASEB J. 1997. PMID: 9039955 Review.

7

Junior scientists spotlight social bonds in seminars for diversity, equity, and inclusion in STEM.

Boyle EA, Goldberg G, Schmok JC, Burgado J, Izidro Layng F, Grunwald HA, Balotin KM, Cuoco MS, Chang KC, Ecklu-Mensah G, Arakaki AKS, Ahmed N, Garcia Arceo X, Jagannatha P, Pekar J, Iyer M; DASL Alliance; Yeo GW. Boyle EA, et al. Among authors: arakaki aks. PLoS One. 2023 Nov 2;18(11):e0293322. doi: 10.1371/journal.pone.0293322. eCollection 2023. PLoS One. 2023. PMID: 37917746 Free PMC article.

8

α-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis.

Arakaki AKS, Pan WA, Wedegaertner H, Roca-Mercado I, Chinn L, Gujral TS, Trejo J. Arakaki AKS, et al. J Cell Sci. 2021 Apr 15;134(8):jcs254888. doi: 10.1242/jcs.254888. Epub 2021 Apr 22. J Cell Sci. 2021. PMID: 33722977 Free PMC article.

9

The α-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling.

Arakaki AKS, Pan WA, Lin H, Trejo J. Arakaki AKS, et al. J Biol Chem. 2018 Mar 2;293(9):3350-3362. doi: 10.1074/jbc.RA117.001516. Epub 2018 Jan 18. J Biol Chem. 2018. PMID: 29348172 Free PMC article.

10

Marker metabolites can be therapeutic targets as well.

Arakaki AK, Skolnick J, McDonald JF. Arakaki AK, et al. Nature. 2008 Nov 27;456(7221):443. doi: 10.1038/456443c. Nature. 2008. PMID: 19037294 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year